JOSEPH JIMENEZ
CIK 1199095 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.47M
Companies
9
Total Filings
89
Lifetime Open-Market Net
$3.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PG | Director | 37,016 | $144.26 | $5.34M | $0 | 42 | 2026-06-10 |
| QNT | Director | 5,833 | — | — | $4.00M | 1 | 2026-06-08 |
| GM | Director | — | $86.39 | — | $0 | 7 | 2026-01-05 |
| IPSC | Director | — | $1.93 | — | $0 | 5 | 2025-06-16 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Director | 21,974 | $22.26 | $489.1K | $0 | 3 | 2023-07-21 |
| General Motors Co (GM.WS.B) Delisted | Director | — | — | — | $0 | 4 | 2019-01-03 |
| General Motors Co (GM.WS.C) Delisted | Director | 32,330 | — | — | $1.02M | 1 | 2015-08-03 |
| CL | Director | 22,950 | $92.93 | $2.13M | $0 | 24 | 2015-01-05 |
| BLUE NILE INC (NILE) Delisted | Director | 5,671 | $0.12 | $695 | -$1.83M | 2 | 2008-05-21 |
Recent Filings · Page 3 of 9
89 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-13 | PG | Grant (A) | +296 | $0 | EDGAR |
| 2023-07-21 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-29 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | PG | Grant (A) | +311 | $0 | EDGAR |
| 2023-03-15 | PG | Grant (A) | +287 | $0 | EDGAR |
| 2023-01-04 | GM | Grant (A) | — | $0 | EDGAR |
| 2022-12-14 | PG | Grant (A) | +292 | $0 | EDGAR |
| 2022-10-12 | PG | Grant (A) | +1,610 | $0 | EDGAR |
| 2022-09-15 | PG | Grant (A) | +290 | $0 | EDGAR |
| 2022-06-22 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.